Printer Friendly

ENDOTRONICS, INC. RECEIVES $2 MILLION LINE OF CREDIT

 ENDOTRONICS, INC. RECEIVES $2 MILLION LINE OF CREDIT
 MINNEAPOLIS, June 30 /PRNewswire/ -- Endotronics, Inc.


(NASDAQ: ENDO) today announced that it received a $2 million line of credit form The Bank of Bloomfield Hills, Bloomfield Hills, Mich. The line of credit is secured by a three-year $2 million letter of credit from Swiss Credit Bank obtained by INTEGRA Holding AG of Switzerland, a significant shareholder of the company. Endotronics intends to utilize the line of credit for working capital, repayment of debt and general corporate purposes.
 Richard E. Sakowicz, president and chief operating officer of Endotronics, said, "This funding will facilitate the implementation of our growth strategy. We view INTEGRA's support as extremely positive and indicative of their confidence in the future we are building."
 Endotronics, Inc., headquartered in Minneapolis, is dedicated to providing cell processing products and services to meet the needs of human health care and biotechnology markets worldwide. The company is a recognized leader in hollow fiber cell culture instrumentation with more than 675 instruments installed worldwide.
 -0- 6/30/92
 /CONTACT: Yvonne L. Marschner-Bova, investor relations director, or Mary J. Lore, chief financial officer, Endotronics, Inc., 313-871-7350/
 (ENDO) CO: Endotronics, Inc.; The Bank of Bloomfield Hills ST: Minnesota, Michigan IN: MTC FIN SU:


JG -- DE014 -- 5143 06/30/92 11:24 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 30, 1992
Words:215
Previous Article:MAXWELL STAKE IN AFFYMAX SOLD
Next Article:COMMAND SECURITY ANNOUNCES YEAR END RESULTS
Topics:


Related Articles
ENDOTRONICS DISCONTINUES DISTRIBUTION AGREEMENT WITH VENTREX LABORATORIES -- SIGNS LETTER OF INTENT WITH NORTHUMBRIA BIOLOGICALS
ENDOTRONICS, INC. RECEIVES $1 MILLION PURSUANT TO INVESTMENT AGREEMENT WITH INTEGRA HOLDING AG OF SWITZERLAND
ENDOTRONICS RECEIVES JAPANESE PATENT ON CELL CULTURE TECHNOLOGY
ENDOTRONICS, INC. ANNOUNCES PURCHASE OF OPTICELL(TM) CELL CULTURE PRODUCT LINE FROM CHARLES RIVER LABORATORIES
ENDOTRONICS, INC. RECEIVES EUROPEAN PATENT ON SCALABLE OXYCELL CELL CULTURE TECHNOLOGY
ENDOTRONICS, INC. ANNOUNCES RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED JUNE 30, 1992
ENDOTRONICS, INC. AND WHEATON SCIENCE PRODUCTS, INC. ANNOUNCE MARKETING AND DISTRIBUTION AGREEMENT
ENDOTRONICS, INC. SIGNS STRATEGIC COOPERATION AGREEMENT WITH TECNOMARA AG OF SWITZERLAND
ENDOTRONICS REPORTS FOURTH-QUARTER AND FISCAL 1992 YEAR-END RESULTS
ENDOTRONICS, INC. PURCHASES VERAX CORPORATION PRODUCT LINE

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters